Expression of caveolin-1 in human breast carcinoma
LIU Xiao-Xu,KANG Hua-Feng,WANG Xi-Jing,DAI Zhi-Jun
2008-01-01
Abstract:AIM:To investigate the expression of caveolin-1 in human breast cancer and its relationship with clinopathological features.METHODS:By immunohistochemical SP method,the expression of caveolin-1 in 120 cases of breast cancer was evaluated,and its relation with clinical and pathological features was analyzed.RESULTS:The caveolin-1 positive expression rate of clinical stageⅠ(69.05%,29/42)and stageⅡ(66.68%,36/54)was higher than that of stage Ⅲ(37.50%,9/24).The caveolin-1 positive expression rate of axillary negative group(73.47%,36/49)was higher than that of axillary positive group(53.5%,38/71).The caveolin-1 positive expression rate of ER(+)group(70.69%,41/58)was higher than that of ER(-)group(53.23%,33/6).The caveolin-1 positive expression rate of HER-2(+)group(47.06%,16/34)was lower than that of HER-2(-)group(67.44%,58/86)with statistical significance(P<0.05).The caveolin-1 positive expression rate of PR(+)group(64.71%,33/51)was higher than that of PR(-)group(59.42%,41/69).The caveolin-1 positive expression rate of histological gradeⅠ(74.29%,26/35),gradeⅡ(56.90%,33/58)and gradeⅢ(55.56%,15/27)showed no significant difference(P>0.05).CONCLUSION:The expression of caveolin-1 correlates with ER expression,and inversely relates with clinical stage,axillary metastasis and HER-2 expression,indicating that it may be an anti-oncogene.Loss of caveolin-1 may play an important role in the development and metastasis of breast cancer,and its biological function may relate with ER and HER-2.